Tokio Marine Asset Management Co. Ltd. Invests $11.99 Million in R1 RCM Inc. (NASDAQ:RCM)

Tokio Marine Asset Management Co. Ltd. acquired a new stake in R1 RCM Inc. (NASDAQ:RCM) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 845,900 shares of the healthcare provider’s stock, valued at approximately $11,986,000. Tokio Marine Asset Management Co. Ltd. owned about 0.20% of R1 RCM as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Dimensional Fund Advisors LP lifted its stake in shares of R1 RCM by 4.5% during the second quarter. Dimensional Fund Advisors LP now owns 3,154,888 shares of the healthcare provider’s stock worth $39,624,000 after buying an additional 136,808 shares during the period. Boston Partners boosted its stake in shares of R1 RCM by 4,976.6% in the first quarter. Boston Partners now owns 2,570,371 shares of the healthcare provider’s stock worth $32,784,000 after buying an additional 2,519,739 shares during the last quarter. First Light Asset Management LLC boosted its position in R1 RCM by 212.8% in the 1st quarter. First Light Asset Management LLC now owns 2,552,325 shares of the healthcare provider’s stock worth $32,874,000 after purchasing an additional 1,736,346 shares in the last quarter. Sea Cliff Partners Management LP lifted its stake in shares of R1 RCM by 14.3% in the 2nd quarter. Sea Cliff Partners Management LP now owns 2,437,450 shares of the healthcare provider’s stock valued at $30,614,000 after purchasing an additional 305,672 shares during the period. Finally, Empyrean Capital Partners LP purchased a new position in R1 RCM during the second quarter worth approximately $26,376,000. 61.10% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

RCM has been the topic of a number of research analyst reports. Stephens lowered R1 RCM from an “overweight” rating to an “equal weight” rating in a research note on Thursday, August 1st. TD Cowen reaffirmed a “hold” rating and set a $14.30 target price (down previously from $20.00) on shares of R1 RCM in a report on Monday, August 5th. Cantor Fitzgerald reissued a “neutral” rating and issued a $14.30 price target on shares of R1 RCM in a research note on Friday, October 4th. Leerink Partners cut shares of R1 RCM from an “outperform” rating to a “market perform” rating and dropped their price objective for the company from $17.00 to $14.30 in a research note on Thursday, August 1st. Finally, Leerink Partnrs cut R1 RCM from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 1st. Thirteen equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat, R1 RCM presently has a consensus rating of “Hold” and a consensus price target of $15.41.

R1 RCM Price Performance

Shares of NASDAQ RCM remained flat at $14.30 during mid-day trading on Thursday. 473,478 shares of the company were exchanged, compared to its average volume of 3,419,815. The firm has a market capitalization of $6.04 billion, a price-to-earnings ratio of -95.33 and a beta of 0.84. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.79 and a current ratio of 1.79. R1 RCM Inc. has a fifty-two week low of $8.87 and a fifty-two week high of $15.12. The company has a fifty day moving average of $14.20 and a two-hundred day moving average of $13.37.

R1 RCM (NASDAQ:RCM) last posted its quarterly earnings data on Tuesday, November 5th. The healthcare provider reported ($0.05) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.04). R1 RCM had a negative return on equity of 2.18% and a negative net margin of 2.48%. The firm had revenue of $656.80 million during the quarter, compared to the consensus estimate of $640.93 million. R1 RCM’s revenue was up 14.7% on a year-over-year basis. As a group, analysts predict that R1 RCM Inc. will post -0.38 EPS for the current fiscal year.

R1 RCM Company Profile

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.